Köpeklerde İmmun Aracılı Göz Hastalıkları

Abstract

Bağışıklık sistemi vücudun en karmaşık ve kapsamlı parçalarından birisidir. Canlının yaşamı boyunca karşılaşabi- leceği potansiyel patojenlerin etkili bir şekilde eliminasyonunu sağlamak için gelişmiştir. Vücudun bu savunma sistemi, fizyolojik düzeni bozan patojenler yerine konağa yönlendirildiğinde otoimmun hastalıklar ortaya çıkar. Göz, vücuttan bağımsız olarak kendi içinde lokal bağışıklığı sağlayıp korumak ve kontrol altına almak için organa özgü immunolojik bir yapı ile şekillenmiştir. Göz içinde herhangi bir patojene ya da yerleşik bulunan hücre gruplarına verilen anormal immun yanıt sonucu oluşacak patolojik değişimler görmeyi tehdit edebilir. Köpeklerde özellikle gözün anterior segmen- tinde bulunan yapılara karşı istenmeyen immunolojik reaksiyonlar ortaya çıkabilmektedir. İmmun aracılı hastalıkların klinik muayene ve laboratuvar testleri ile erken tanısı, hastalığın tedavisi ve prognozu açısından önem arz eder. Bu derlemenin amacı, köpeklerde en sık karşılaşılan immun sistem kaynaklı göz hastalıklarının etiyoloji, klinik görünüm, histopatolojik bulgular ve tedavisi hakkında bilgi vermektir.

Keywords

• Bağışıklık
• bulbus okuli
• konjunktiva
• otoimmun
• Autoimmune
• bulbus oculi
• conjunctiva
• immunity

Immune-Mediated Eye Diseases in Dogs

Abstract

The immune system is one of the most complex and comprehensive parts of the body. It has been developed to effectively eliminate potential pathogens that may encounter throughout the animals’ life. Autoimmune diseases occur when this defence system of the body is directed to the host instead of pathogens that disrupt the physiological order. The eye has consisted with an organ-specific immunological structure in order to maintain and control local immunity, independent of the body. Pathological changes that will occur as a result of an abnormal immune response to any pathogen or resident cell groups in the eye may threaten the vision. Undesirable immunological reactions can occur in dogs, especially against structures in the anterior segment of the eye. Early diagnosis of immune-mediated diseases with clinical examination and laboratory tests is important for the treatment and prognosis of the disease. The purpose of this review is to provide information about the etiology, clinical appearance, histopathological findings and treatment of the most common immune system-related eye diseases in dogs.

Keywords

• Autoimmune
• bulbus oculi
• conjunctiva
• immunity

References

1. Andrew SE. Immune-mediated canine and feline keratitis. Vet Clin North Am Small Anim 2008; 38(2): 269-90.
2. Beteg F, Lelescu CA, Urda-Cimpean AE, Taulescu MA, Muresan C. Long-term prospective assessment of subconjunctival triamcinolone acetonide in addition to topical therapy in the management of chronic superficial keratitis. Ankara Üniv Vet Fak Derg 2020; 68(1): 61-8.
3. Castillo DU. Chronic superficial keratitis. Veterinariae Zootecnia (On Line) 2019; 13(2): 24-30.
4. Dall’Ara P, Turin L. Immunology of the canine eye in health and disease: A concise review. Vet Med 2019; 64(1): 1-17.
5. Day MJ, Crispin SM. Immune mediated ocular dis- ease. Day MJ. ed. In: Clinical immunology of the dog and cat. Florida: CRC Press, 2011; pp. 263-85.
6. De Jonge B, Van Brantegem L, Chiers K. Infectious canine hepatitis, not only in the textbooks: A brief review and three case reports. Vlaams Di- ergeneeskundig Tijdschrift 2020; 89(5): 284-91.
7. Dodi PL.Immune-mediated keratoconjunctivitis sicca in dogs: Current perspectives on management. Vet Med 2015; 30(6): 341-47.
8. Ergin I, Senel OO, Koc B. Kedi kornea nekrozlarının konjunktival flep ile sağaltımı. Vet Hek Der Derg 2016; 87(1): 44-54.

9. Ergin I. Köpeklerde pigmenter keratitis. Erciyes Üniv Sag Bil Derg 2018; 27: 55-9.
10. Ergin I, Sainkaplan S, Senel OO. Clinical assessment of chronic superficial keratitis (überreiter’s syndrome) in dogs: A retrospective study (2012-2019). Veterinaria 2021; 70(2): 185-95.
11. Gelatt KN. Canine Cornea: Diseases and Surgery Essentials of Veterinary Ophthalmology. New York: John Wiley and Sons, 2013; pp. 216-48.
12. Gelatt, KN, Plummer CE. Canine conjunctiva and nictitating membrane (nictitans). Gelatt KN, Plummer CE. eds. In: Color Atlas of Veterinary Ophthalmology. New York: John Wiley and Sons, 2017; pp. 97-110.
13. Gershwin, LJ. Current and newly emerging autoimmune diseases. Vet Clin North Am Small Anim Pract 2018; 48(2): 323-38.
14. Grahn B, Peiffer R, Wilcock B. Histologic manifestations of disorders of the uvea. Grahn B, Peiffer R, Wilcock B. eds. In: Histologic Basis of Ocular Disease in Animals. New York: John Wiley and Sons, 2018; pp. 197-254.
15. Goodale E. Pemphigus foliaceous. Can Vet J 2019; 60(3): 311-3.
16. Hamzianpour N, Heinrich, C, Jones, R. G, McElroy, P, Wilson, N, Scurrell E. Clinical and pathological findings in three dogs with a corneocentric presentation of nodular granulomatous episcleritis. Vet Ophthalmol 2019; 22(4): 529-37.
17. Maggs DJ. Cornea and sclera. Maggs DJ, Miller P, Ofri R. eds. In: Slatter's Fundamentals of Veterinary Ophthalmology. Missouri: Saunders Elsevier, 2013; pp. 184-219.
18. Moore PA. Cornea and sclera. Martin CL, Pickett JP, Spiess BM. eds. In: Ophthalmic Disease in Veterinary Medicine. Florida: CRC Press, 2019; pp. 315- 409.
19. Peterson CWM, Carter R, Bentley E, Murphy CJ, Chandler HL. Heat-shock protein expression in canine corneal wound healing. Vet Ophthalmol 2015; 19 (3): 262-66.
20. Petrick SW, Van Rensburg IBJ. Corneal anatomic differences in the aetiology of chronic superficial keratitis. J Small Anim Pract 2008; 30 (8): 449-53.
21. Pickett JP. Lacrimal apparatus. Martin CL, Pickett JP, Spiess BM. eds. In: Ophthalmic disease in Veterinary Medicine. Florida: CRC Press, 2019; pp. 281- 314.
22. Sato K, Kanai K, Ozaki M, Kagawa T, Kita M, Yama- shita Y, Tajima K. Preventive effects of tyrosol, a natural phenolic compound, on anterior uveitis induced by anterior chamber paracentesis in healthy beagle dogs. J Vet Med Sci 2019; 81(4): 573-6.
23. Sgrignoli MR, Silva DA, Nascimento FF, Sgrignoli DAM, Nai GA, da Silva MG, Andrade SF. Reduction in the inflammatory markers CD4, IL-1, IL-6 and TNFα in dogs with keratoconjunctivitis sicca treated topically with mesenchymal stem cells. Stem Cell Res 2019; 39: 1-7.
24. Spiess BM. Conjunctiva and third eyelid. Martin CL, Pickett JP, Spiess BM. eds. In: Ophthalmic Disease in Veterinary Medicine. Florida: CRC Press, 2019; pp. 235-80.
25. Tham HL, Linder KE, Olivry T. Autoimmune diseases affecting skin melanocytes in dogs, cats and horses: Vitiligo and the uveodermatological syndrome: A comprehensive review. BMC Vet Res 2019; 15 (1): 1-17.
26. Urban-Chmiel R, Balicki I, Wernicki A. Heat shock proteins 70 kDa, eosinophil cationic protein, and nitric oxide during chronic superficial keratitis in dogs. Top Companion Anim Med 2017; 32(1): 8-12.
27. Varandas C, Cartaxeiro C, Lourenço AM, Delgado E, Gil S. Selected cytokine expression in dogs with alergic conjunctivitis: Correlation with disease activity. Res Vet Sci 2020; 130: 33-40.
28. Wasik B, Adkins E. Canine anterior uveitis. Compen- dium Contin Educ Vet 2010; 32(11): 1-11.
29. Williams DL, Tighe A. Immunohistochemical evaluation of lymphocyte populations in the nictitans glands of normal dogs and dogs with keratoconjunctivitis sicca. Open Vet J 2018; 8 (1): 47-52.
30. Zarfoss MK, Tusler CA, Kass PH, Montgomery K, Lim CC, Mowat F, Thomasy SM. Clinical findings and outcomes for dogs with uveodermatologic syndrome. JAVMA 2018; 252(10): 1263-71.